Outcome of infections with extended spectrum beta-lactamase producing organisms in children

Journal of Pediatric Infectious Diseases

Volumn 3, Issue 4, 2008, Pages 229-233

  Jhaveri, Ravi ^a   Bronstein, David ^b   Sollod, Janet ^c   Kitchen, Christina ^d   Krogstad, Paul ^d  

^a DUKE CHILDREN S HOSPITAL   (United States)

^b KAISER PERMANENTE   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobials; Children; E. coli; ESBL; Extended spectrum beta lactamases; K. pneumoniae; Pediatrics

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CORTICOSTEROID; EXTENDED SPECTRUM BETA LACTAMASE; GANCICLOVIR;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; HOSPITALIZED CHILD; HUMAN; INFECTION CONTROL; LENGTH OF STAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

EID: 58149357484     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0035-1556994     Document Type: Article

References (24)

1. S.R. Arnold and A.J. Bush, Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community, Ambul Pediatr 6 (2006), 225-229.
2. D.R. Nash, J. Harman, E.R. Wald and K.J. Kelleher, Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections, Arch Pediatr Adolesc Med 156 (2002), 1114-1119.
3. S. Dowell, S. Marcy, W. Phillips, M. Gerber and B. Schwartz, Otitis media-Principles of judicious use of antimicrobial agents, Pediatrics 101 (1998), 165-171.
4. S. Dowell, S.M. Marcy, W.R. Phillips, M.A. Gerber and B. Schwartz, Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections, Pediatrics 101 (1998), 163-165.
5. M.Z. David, S.E. Crawford, S. Boyle-Vavra, M.A. Hostetler and D.C. Kim, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates, Emerg Infect Dis 12 (2006), 631-637.
6. R.M. Klevens, M.A. Morrison, J. Nadle et al., Invasive methicillin-resistant Staphylococcus aureus infections in the United States, JAMA 298 (2007), 1763-1771.
7. T.J. Ochoa, J. Mohr, A. Wanger, J.R. Murphy and G.P. Heresi, Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients, Emerg Infect Dis 11 (2005), 966-968.
8. M. Gniadkowski, Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms, Clin Microbiol Infect 7 (2001), 597-608.
9. G.A. Jacoby and P. Han, Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli, J Clin Microbiol 34 (1996), 908-911.
10. M. Gniadkowski, A. Palucha, P. Grzesiowski and W. Hryniewicz, Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: Clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene, Antimicrob Agents Chemother 42 (1998), 3079-3085.
11. M. Gniadkowski, I. Schneider, R. Jungwirth, W. Hryniewicz and A. Bauernfeind, Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: Identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases, Antimicrob Agents Chemother 42 (1998), 514-520.
12. G.A. Jacoby, Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams, Infect Dis Clin North Am 11 (1997), 875-887.
13. J.A. Rebuck, K.M. Olsen, P.D. Fey, A.N. Langnas and M.E. Rupp, Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population, Clin Infect Dis 31 (2000), 1368-1372.
14. E. Lautenbach, J.B. Patel, W.B. Bilker, P.H. Edelstein and N.O. Fishman, Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes, Clin Infect Dis 32 (2001), 1162-1171.
15. J.D. Pitout and K.B. Laupland, Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern, Lancet Infect Dis 8 (2008), 159-166.
16. Y.K. Kim, H. Pai, H.J. Lee et al., Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome, Antimicrob Agents Chemother 46 (2002), 1481-1491.
17. T.E. Zaoutis, M. Goyal, J.H. Chu et al., Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children, Pediatrics 115 (2005), 942-949.
18. J. Lee, H. Pai, Y.K. Kim et al., Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy, J Antimicrob Chemother 60 (2007), 629-637.
19. S.Y. Lee, S. Kotapati, J.L. Kuti, C.H. Nightingale and D.P. Nicolau, Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: A matched cohort study, Infect Control Hosp Epidemiol 27 (2006), 1226-1232.
20. A.J. Zillich, J.M. Sutherland, S.J. Wilson et al., Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals, Infect Control Hosp Epidemiol 27 (2006), 1088-1095.
21. J. Le, T. Nguyen, M. Okamoto, S. McKamy and J.M. Lieberman, Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit, Pediatr Infect Dis J 27 (2008), 314-318.
22. C. Mammina, P. Di Carlo, D. Cipolla et al., Surveillance of multidmg-resistant Gram-negative bacilli in a neonatal intensive care unit: Prominent role of cross transmission, Am J Infect Control 35 (2007), 222-230.
23. A. Kola, M. Holst, I.F. Chaberny, S. Ziesing, S. Suerbaum and P. Gastmeier, Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: Experience from a three-year period, J Hosp Infect 66 (2007), 46-51.
24. T. Spanu, F. Luzzaro, M. Perilli et al., Occurrence of extended-spectrum beta-lactamases in members ofthe family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs, Antimicrob Agents Chemother 46 (2002), 196-202.